Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep;13(3):235-237.
doi: 10.14802/jmd.20011. Epub 2020 Sep 9.

Anti-GABAB Receptor Encephalitis Presenting with Atypical Corticobasal Syndrome in a Patient with Parkinson's Disease

Noor Sharizat Abdullah  1 , Tan Hui Jan  1 , Rabani Remli  1 , Shahizon Azura Mohamad Mukari  2 , Norlinah Mohamed Ibrahim  1
Affiliations

Anti-GABAB Receptor Encephalitis Presenting with Atypical Corticobasal Syndrome in a Patient with Parkinson's Disease

Noor Sharizat Abdullah et al. J Mov Disord. 2020 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

The authors have no financial conflicts of interest.

Figures

Figure 1.
Figure 1.
MRI of the brain at presentation demonstrated multifocal cortical and subcortical white matter T2 hyperintensity in the right hippocampus and right middle and superior temporal gyri (A and B), both cingulate gyri (R > L), the right superior frontal and rectus gyri (B and C) and the right insular cortex (B), with mild restricted diffusion of the cortex and T2 shine-through within the subcortical white matter on DWI (D) and the corresponding ADC map (E), without hemorrhage (not shown) or postcontrast enhancement (not shown). Follow-up MRI 6 weeks later demonstrated decreased T2 hyperintensity in the cortex and subcortical white matter of the original lesions (F).
See this image and copyright information in PMC

References

    1. Armstrong MJ, Litvan I, Lang AE, Bak TH, Bhatia KP, Borroni B, et al. Criteria for the diagnosis of corticobasal degeneration. Neurology. 2013;80:496–503. - PMC - PubMed
    1. Sheetal SK, Mathew R, Peethambaran B. Hashimoto’s encephalopathy as a treatable cause of corticobasal disease. Ann Indian Acad Neurol. 2016;19:285–286. - PMC - PubMed
    1. Lee W, Simpson M, Ling H, McLean C, Collins S, Williams DR. Characterising the uncommon corticobasal syndrome presentation of sporadic Creutzfeldt-Jakob disease. Parkinsonism Relat Disord. 2013;19:81–85. - PubMed
    1. van Coevorden-Hameete MH, de Bruijn MAAM, de Graaff E, Bastiaansen DAEM, Schreurs MWJ, Demmers JAA, et al. The expanded clinical spectrum of anti-GABABR encephalitis and added value of KCTD16 autoantibodies. Brain. 2019;142:1631–1643. - PMC - PubMed
    1. Lin J, Li C, Li A, Liu X, Wang R, Chen C, et al. Encephalitis with antibodies against the GABAB receptor: high mortality and risk factors. Front Neurol. 2019;10:1030. - PMC - PubMed

LinkOut - more resources